|Revised response criteria for malignant lymphoma|
BD Cheson, B Pfistner, ME Juweid, RD Gascoyne, L Specht, SJ Horning, ...
Journal of clinical oncology 25 (5), 579-586, 2007
|Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas|
BD Cheson, SJ Horning, B Coiffier, MA Shipp, RI Fisher, JM Connors, ...
Journal of clinical oncology 17 (4), 1244-1244, 1999
|Factors affecting late mortality from heart disease after treatment of Hodgkin's disease|
SL Hancock, MA Tucker, RT Hoppe
Jama 270 (16), 1949-1955, 1993
|Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression|
YH Kim, HL Liu, S Mraz-Gernhard, A Varghese, RT Hoppe
Archives of dermatology 139 (7), 857-866, 2003
|Breast cancer after treatment of Hodgkin's disease|
SL Hancock, MA Tucker, RT Hoppe
JNCI: Journal of the National Cancer Institute 85 (1), 25-31, 1993
|Tolerance and chimerism after renal and hematopoietic-cell transplantation|
JD Scandling, S Busque, S Dejbakhsh-Jones, C Benike, MT Millan, ...
New England Journal of Medicine 358 (4), 362-368, 2008
|PD-L1 and PD-L2 genetic alterations define classical Hodgkin lymphoma and predict outcome|
MGM Roemer, RH Advani, AH Ligon, Y Natkunam, RA Redd, H Homer, ...
Journal of Clinical Oncology 34 (23), 2690, 2016
|Cardiac disease following treatment of Hodgkin's disease in children and adolescents.|
SL Hancock, SS Donaldson, RT Hoppe
Journal of Clinical Oncology 11 (7), 1208-1215, 1993
|Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University.|
MP Mac Manus, RT Hoppe
Journal of Clinical Oncology 14 (4), 1282-1290, 1996
|Psychosocial problems among survivors of Hodgkin's disease.|
P Fobair, RT Hoppe, J Bloom, R Cox, A Varghese, D Spiegel
Journal of clinical Oncology 4 (5), 805-814, 1986
|TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas …|
YH Kim, R Willemze, N Pimpinelli, S Whittaker, EA Olsen, A Ranki, ...
Blood, The Journal of the American Society of Hematology 110 (2), 479-484, 2007
|Female reproductive potential after treatment for Hodgkin's disease|
SJ Horning, RT Hoppe, HS Kaplan, SA Rosenberg
New England Journal of Medicine 304 (23), 1377-1382, 1981
|Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG)|
L Specht, J Yahalom, T Illidge, AK Berthelsen, LS Constine, HT Eich, ...
International Journal of Radiation Oncology* Biology* Physics 89 (4), 854-862, 2014
|In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study|
JD Brody, WZ Ai, DK Czerwinski, JA Torchia, M Levy, RH Advani, YH Kim, ...
Journal of clinical oncology 28 (28), 4324, 2010
|Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United …|
EA Olsen, S Whittaker, YH Kim, M Duvic, HM Prince, SR Lessin, GS Wood, ...
Journal of Clinical Oncology 29 (18), 2598, 2011
|European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell …|
NJ Senff, EM Noordijk, YH Kim, M Bagot, E Berti, L Cerroni, R Dummer, ...
Blood, The Journal of the American Society of Hematology 112 (5), 1600-1609, 2008
|Stanford V and radiotherapy for locally extensive and advanced Hodgkin’s disease: mature results of a prospective clinical trial|
SJ Horning, RT Hoppe, S Breslin, NL Bartlett, BW Brown, SA Rosenberg
Journal of Clinical Oncology 20 (3), 630-637, 2002
|Central nervous system involvement in non‐Hodgkin's lymphoma: An analysis of 105 cases|
FR Mackintosh, TV Colby, WJ Podolsky, JS Burke, RT Hoppe, ...
Cancer 49 (3), 586-595, 1982
AD Zelenetz, JS Abramson, RH Advani, CB Andreadis, JC Byrd, ...
Journal of the National Comprehensive Cancer Network 8 (3), 288-334, 2010
|CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma|
HL Liu, RT Hoppe, S Kohler, JD Harvell, S Reddy, YH Kim
Journal of the American Academy of Dermatology 49 (6), 1049-1058, 2003